Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years. METHODS: This is a retrospective observational cohort study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannou, Adam, Patel, Rishi K., Razvi, Yousuf, Porcari, Aldostefano, Sinagra, Gianfranco, Venneri, Lucia, Bandera, Francesco, Masi, Ambra, Williams, Georgina E., O’Beara, Sophie, Ganesananthan, Sharmananthan, Massa, Paolo, Knight, Daniel, Martinez-Naharro, Ana, Kotecha, Tushar, Chacko, Liza, Brown, James, Rauf, Muhammad U., Manisty, Charlotte, Moon, James, Lachmann, Helen, Wechelakar, Ashutosh, Petrie, Aviva, Whelan, Carol, Hawkins, Philip N., Gillmore, Julian D., Fontana, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698091/
https://www.ncbi.nlm.nih.gov/pubmed/36325894
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698091/
https://www.ncbi.nlm.nih.gov/pubmed/36325894
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060852

Ejemplares similares